155 related articles for article (PubMed ID: 28480403)
1. FABRICATION AND EVALUATION OF SMART NANOCRYSTALS OF ARTEMISININ FOR ANTIMALARIAL AND ANTIBACTERIAL EFFICACY.
Shah SMH; Ullah F; Khan S; Shah SMM; Isreb M
Afr J Tradit Complement Altern Med; 2017; 14(1):251-262. PubMed ID: 28480403
[TBL] [Abstract][Full Text] [Related]
2. Smart nanocrystals of artemether: fabrication, characterization, and comparative in vitro and in vivo antimalarial evaluation.
Shah SM; Ullah F; Khan S; Shah SM; de Matas M; Hussain Z; Minhas MU; AbdEl-Salam NM; Assi KH; Isreb M
Drug Des Devel Ther; 2016; 10():3837-3850. PubMed ID: 27920499
[TBL] [Abstract][Full Text] [Related]
3. Formation, physical stability and in vitro antimalarial activity of dihydroartemisinin nanosuspensions obtained by co-grinding method.
Chingunpitak J; Puttipipatkhachorn S; Chavalitshewinkoon-Petmitr P; Tozuka Y; Moribe K; Yamamoto K
Drug Dev Ind Pharm; 2008 Mar; 34(3):314-22. PubMed ID: 18363147
[TBL] [Abstract][Full Text] [Related]
4. Fabrication and characterization of glimepiride nanosuspension by ultrasonication-assisted precipitation for improvement of oral bioavailability and in vitro α-glucosidase inhibition.
Rahim H; Sadiq A; Khan S; Amin F; Ullah R; Shahat AA; Mahmood HM
Int J Nanomedicine; 2019; 14():6287-6296. PubMed ID: 31496686
[TBL] [Abstract][Full Text] [Related]
5. Aceclofenac nanocrystals with enhanced in vitro, in vivo performance: formulation optimization, characterization, analgesic and acute toxicity studies.
Rahim H; Sadiq A; Khan S; Khan MA; Shah SMH; Hussain Z; Ullah R; Shahat AA; Ibrahim K
Drug Des Devel Ther; 2017; 11():2443-2452. PubMed ID: 28860715
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and antimalarial activity of ethylene glycol oligomeric ethers of artemisinin.
Steyn M; N'Da DD; Breytenbach JC; Smith PJ; Meredith S; Breytenbach WJ
J Pharm Pharmacol; 2011 Feb; 63(2):278-86. PubMed ID: 21235593
[TBL] [Abstract][Full Text] [Related]
7. Preparation and Characterization of Stable Nanosuspension for Dissolution Rate Enhancement of Furosemide: A Quality by Design (QbD) Approach.
Marzan AL; Tabassum R; Jahan B; Asif MH; Reza HM; Kazi M; Alshehri SM; de Matas M; Shariare MH
Curr Drug Deliv; 2018; 15(5):672-685. PubMed ID: 29359667
[TBL] [Abstract][Full Text] [Related]
8. Antimalarial activities of (+)-deoxoartemisitene and its novel C-11, 13 derivatives.
Jung M; Lee K; Jung H; Kendrick H; Yardley V; Croft SL
Bioorg Med Chem Lett; 2004 Apr; 14(8):2001-3. PubMed ID: 15050646
[TBL] [Abstract][Full Text] [Related]
9. Fabrication of quercetin nanocrystals: comparison of different methods.
Kakran M; Shegokar R; Sahoo NG; Shaal LA; Li L; Müller RH
Eur J Pharm Biopharm; 2012 Jan; 80(1):113-21. PubMed ID: 21896330
[TBL] [Abstract][Full Text] [Related]
10. Dissolution of artemisinin/polymer composite nanoparticles fabricated by evaporative precipitation of nanosuspension.
Kakran M; Sahoo NG; Li L; Judeh Z
J Pharm Pharmacol; 2010 Apr; 62(4):413-21. PubMed ID: 20604829
[TBL] [Abstract][Full Text] [Related]
11. Quantitative structure-activity relationships of the antimalarial agent artemisinin and some of its derivatives - a DFT approach.
Rajkhowa S; Hussain I; Hazarika KK; Sarmah P; Deka RC
Comb Chem High Throughput Screen; 2013 Sep; 16(8):590-602. PubMed ID: 23597248
[TBL] [Abstract][Full Text] [Related]
12. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
13. Development, characterization and antimalarial efficacy of dihydroartemisinin loaded solid lipid nanoparticles.
Omwoyo WN; Melariri P; Gathirwa JW; Oloo F; Mahanga GM; Kalombo L; Ogutu B; Swai H
Nanomedicine; 2016 Apr; 12(3):801-809. PubMed ID: 26724538
[TBL] [Abstract][Full Text] [Related]
14. Development of surface stabilized candesartan cilexetil nanocrystals with enhanced dissolution rate, permeation rate across CaCo-2, and oral bioavailability.
Jain S; Reddy VA; Arora S; Patel K
Drug Deliv Transl Res; 2016 Oct; 6(5):498-510. PubMed ID: 27129488
[TBL] [Abstract][Full Text] [Related]
15. Nanosizing of a poorly soluble drug: technique optimization, factorial analysis, and pharmacokinetic study in healthy human volunteers.
Elsayed I; Abdelbary AA; Elshafeey AH
Int J Nanomedicine; 2014; 9():2943-53. PubMed ID: 24971006
[TBL] [Abstract][Full Text] [Related]
16. Rifampicin nanocrystals: Towards an innovative approach to treat tuberculosis.
Melo KJC; Henostroza MAB; Löbenberg R; Bou-Chacra NA
Mater Sci Eng C Mater Biol Appl; 2020 Jul; 112():110895. PubMed ID: 32409052
[TBL] [Abstract][Full Text] [Related]
17. Preparation of stable nitrendipine nanosuspensions using the precipitation-ultrasonication method for enhancement of dissolution and oral bioavailability.
Xia D; Quan P; Piao H; Piao H; Sun S; Yin Y; Cui F
Eur J Pharm Sci; 2010 Jul; 40(4):325-34. PubMed ID: 20417274
[TBL] [Abstract][Full Text] [Related]
18. Fabrication of surfactant-stabilized nanosuspension of naringenin to surpass its poor physiochemical properties and low oral bioavailability.
Singh MK; Pooja D; Ravuri HG; Gunukula A; Kulhari H; Sistla R
Phytomedicine; 2018 Feb; 40():48-54. PubMed ID: 29496174
[TBL] [Abstract][Full Text] [Related]
19. Antimalarial activity of thiophenyl- and benzenesulfonyl-dihydroartemisinin.
Lee S; Oh S; Park GM; Kim TS; Ryu JS; Choi HK
Korean J Parasitol; 2005 Sep; 43(3):123-6. PubMed ID: 16192755
[TBL] [Abstract][Full Text] [Related]
20. Fabrication of fenofibrate nanocrystals by probe sonication method for enhancement of dissolution rate and oral bioavailability.
Ige PP; Baria RK; Gattani SG
Colloids Surf B Biointerfaces; 2013 Aug; 108():366-73. PubMed ID: 23602990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
